WallStSmart
VKTX

Viking Therapeutics Inc

NASDAQ: VKTX · HEALTHCARE · BIOTECHNOLOGY

$30.00
-3.78% today

Updated 2026-05-01

Market cap
$3.63B
P/E ratio
P/S ratio
EPS (TTM)
$-3.19
Dividend yield
52W range
$23 – $43
Volume
2.4M

Viking Therapeutics Inc (VKTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-38.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-234.1%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+0.2%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
-3.7%
2026-04-29
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-04-29$-1.37-48.8%$32.39$31.18-3.7%
2026-02-12$-1.38-54.1%$28.55$29.00+1.6%
2025-10-22$-0.81-20.9%$32.98$33.92+2.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.92$-1.37-48.8%
2025-12-31$-0.90$-1.38-54.1%
2025-09-30$-0.67$-0.81-20.9%
2025-06-30$-0.44$-0.58-31.8%
2025-03-31$-0.31$-0.41-32.3%
2024-12-31$-0.27$-0.32-18.5%
2024-09-30$-0.25$-0.22+12.0%
2024-06-30$-0.27$-0.20+25.9%
2024-03-31$-0.28$-0.26+7.1%
2023-12-31$-0.25$-0.25+0.0%$436000.00
2023-09-30$-0.22$-0.23-4.5%

Frequently asked questions

Has Viking Therapeutics Inc beaten earnings estimates?
Viking Therapeutics Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -38.9% over the last 4 quarters.
How does VKTX stock react to earnings?
VKTX stock has moved an average of +0.2% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.